Trandate (labetalol hydrochloride) tablet label

First Page		Document Content
Date: 2010-11-29 15:22:50 Organic chemistry Scottish inventions Amines Labetalol Salicylamides Antihypertensive drug Methadone Alpha-1 adrenergic receptor Propranolol Chemistry Beta blockers Alcohols		Trandate (labetalol hydrochloride) tablet label Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 194,14 KB Share Document on Facebook

	Identification of two distinct inactive conformations of the ␤2-adrenergic receptor reconciles structural and biochemical observations Ron O. Drora,1, Daniel H. Arlowa,1, David W. Borhania, Morten Ø. Jensena, Stefano DocID: 1qY5s - View Document
	MEDIA RELEASE WARNING – PATIENTS TAKING TAMSULOSIN AND OTHER ALPHA-1 ADRENERGIC RECEPTOR ANTAGONISTS MAY BE AT RISK OF EYE SURGERY COMPLICATIONS. DocID: XJwY - View Document
	MEDIA RELEASE WARNING – PATIENTS TAKING TAMSULOSIN AND OTHER ALPHA-1 ADRENERGIC RECEPTOR ANTAGONISTS MAY BE AT RISK OF EYE SURGERY COMPLICATIONS. DocID: X6cA - View Document
	PRODUCT INFORMATION TRANDATE® (labetalol hydrochloride) Tablets DESCRIPTION: TRANDATE Tablets are adrenergic receptor blocking agents that have both DocID: NkWm - View Document
	AIM 2014-3_12[removed]Dubravko.indd DocID: EHOB - View Document